TNYA News and Press, Tenaya Therapeutics Inc.

2026-03-12 13:03:15 ET Mani Foroohar from Leerink Partners issued a price target of $2.00 for TNYA on 2026-03-12 14:37:00. The adjusted price target was set to $2.00. At the time of the announcement, TNYA was trading at $0.95. The overall price target consensus is at $2....

2026-03-12 12:15:03 ET Leerink Partners analyst issues OUTPERFORM recommendation for TNYA on March 12, 2026 02:37PM ET. The previous analyst recommendation was Outperform. TNYA was trading at $0.907 at issue of the analyst recommendation. The overall analyst consensus : ...

2026-03-11 16:35:53 ET More on Tenaya Therapeutics Tenaya Therapeutics, Inc. (TNYA) Discusses Initial Data From RIDGE-1 Phase Ib/II Trial of TN-401 Gene Therapy for ARVC Prepared Remarks Transcript Tenaya Therapeutics, Inc. (TNYA) Discusses Initial Data From RIDGE-1 Phase Ib...

Reported Promising Data for TN-201 and TN-401 Gene Therapies in Fourth Quarter of 2025; Additional Data Readouts and Pursuit of Regulatory Alignment for Each Program Planned in 2026 New Research Supports TN-301’s Potential in Multiple Indications; Presented Preclinical Data for TN-301 ...

Tenaya’s Highly Selective HDAC6 Inhibitor TN-301 Outperformed Approved Pan-HDAC Inhibitor Givinostat in Improving Muscle Function and Correcting Drivers of DMD Cardiomyopathy  New Data Confirm TN-301’s Differentiated Mechanism and Opportunities to Positively Address Rare an...

New Fortress Energy Inc. (NFE) is expected to report $-1.08 for Q4 2025 Design Therapeutics Inc. (DSGN) is expected to report $-0.38 for Q4 2025 Beta Technologies Inc. Class A (BETA) is expected to report $-0.52 for Q4 2025 Yext Inc. (YEXT) is expected to report $0.06 for Q4 2026 ...

2026-03-08 18:38:24 ET Tenaya Therapeutics, Inc. (TNYA) - This analysis reviews how the stock price reacted during the last 12 earnings periods. The average open to high on the day of earnings was 5.61%. The average open to low on the day of earnings was -5.82%. The average open...

2026-03-08 18:33:25 ET Tenaya Therapeutics, Inc. (TNYA) - Following Earnings Price Analysis was done using last 12 quarters historical earnings. Opening Gap Moves The historical opening gap move in TNYA stock price following earnings has averaged ±3.36% , with a median of 2.75%...

A look at the top 10 most actives in the United States Blue Hat Interactive Entertainment Technology (BHAT) rose 27.2% to $0.0372 on volume of 1,503,563,584 shares Trio Petroleum Corp. (TPET) rose 87.3% to $1.59 on volume of 399,247,798 shares Mobix Labs Inc. (MOBX) rose 5.6% to $0.8659 on ...

2026-03-05 08:54:47 ET More on Alnylam Pharmaceuticals, Tenaya Therapeutics Alnylam Pharmaceuticals, Inc. (ALNY) Presents at TD Cowen 46th Annual Health Care Conference Transcript Alnylam Hit Hard As Investors Forced To Revise Future Profit Expectations Alnylam Pharm...